C07C 311/52
Y being a hetero atom
C07C311/52 (Y being a hetero atom) appears on 310 US grants and 209 published applications in this corpus.
Search patents in C07C- Granted patents
- 310
- Published applications
- 209
- Assignees
- 175
- Inventors
- 776
- Latest grant
- 5 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 6 | 0 |
| 1978 | 3 | 0 |
| 1979 | 0 | 0 |
| 1980 | 4 | 0 |
| 1981 | 5 | 0 |
| 1982 | 5 | 0 |
| 1983 | 1 | 0 |
| 1984 | 5 | 0 |
| 1985 | 0 | 0 |
| 1986 | 5 | 0 |
| 1987 | 4 | 0 |
| 1988 | 5 | 0 |
| 1989 | 5 | 0 |
| 1990 | 7 | 0 |
| 1991 | 2 | 0 |
| 1992 | 2 | 0 |
| 1993 | 11 | 0 |
| 1994 | 8 | 0 |
| 1995 | 6 | 0 |
| 1996 | 7 | 0 |
| 1997 | 16 | 0 |
| 1998 | 6 | 0 |
| 1999 | 8 | 0 |
| 2000 | 13 | 0 |
| 2001 | 8 | 1 |
| 2002 | 26 | 13 |
| 2003 | 12 | 22 |
| 2004 | 18 | 12 |
| 2005 | 6 | 9 |
| 2006 | 3 | 11 |
| 2007 | 6 | 5 |
| 2008 | 7 | 10 |
| 2009 | 3 | 6 |
| 2010 | 3 | 5 |
| 2011 | 5 | 4 |
| 2012 | 4 | 5 |
| 2013 | 6 | 2 |
| 2014 | 1 | 4 |
| 2015 | 6 | 7 |
| 2016 | 8 | 8 |
| 2017 | 5 | 9 |
| 2018 | 4 | 5 |
| 2019 | 7 | 5 |
| 2020 | 3 | 6 |
| 2021 | 4 | 12 |
| 2022 | 2 | 9 |
| 2023 | 7 | 15 |
| 2024 | 7 | 9 |
| 2025 | 7 | 9 |
| 2026 | 4 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- N-phenyl-3-mercaptopropanamide derivatives as metallo-beta-lactamase inhibitors for the treatment of bacterial infections5 May 2026US 12,616,670 B2Helmholtz-Zentrum FüR Infektionsforschung GmbH
- Subtituted sulfonylurea and sulfoximineurea derivatives14 Apr 2026US 12,599,616 B2Zydus Lifesciences Limited
- Actinic ray-sensitive or radiation-sensitive resin composition, resist film, pattern forming method, method for manufacturing electronic device, and compound24 Mar 2026US 12,585,187 B2FUJIFILM Corporation
- Probenecid compounds for the treatment of inflammasome-mediated lung disease17 Mar 2026US 12,577,211 B2Bacainn Biotherapeutics, Ltd.
- Sulfonylurea derivative and medical uses thereof9 Dec 2025US 12,492,166 B2Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Probenecid compounds for the treatment of inflammasome-mediated lung disease8 Oct 2026US 2026/0308131 A1Bacainn Biotherapeutics, Ltd.
- Probenecid compounds for the treatment of inflammasome-mediated dermatological conditions25 Jun 2026US 2026/0176232 A1Bacainn Biotherapeutics, Ltd.
- Modulators of mas-related g-protein receptor x4 and related products and methods23 Apr 2026US 2026/0108482 A1Escient Pharmaceuticals, Inc.
- Protoporphyrinogen oxidase inhibitors12 Mar 2026US 2026/0068883 A1Enko Chem, Inc.
- Compounds and compositions for intracellular delivery of therapeutic agents12 Mar 2026US 2026/0069549 A1ModernaTX, Inc.
Most cited
By later US patents
- Compounds and compositions for intracellular delivery of therapeutic agents88US 10,857,105 B2MordernaTX, Inc. · 2020
- 7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds79US 6,818,634 B2Paratek Pharmaceuticals, Inc. · 2004
- Benzoyl-substituted phenylalanineamides74US 7,687,435 B2BASF SE · 2010
- N-acylsulfonamides, novel mixtures of herbicides and antidotes, and their use60US 6,235,680 B1Hoechst Schering AgrEvo GmbH · 2001
- 13-substituted methacycline compounds59US 6,500,812 B2Paratek Pharmaceuticals, Inc. · 2002